BaharLaderianMD

PubMed

• 34 citations
  Emerging Therapeutic Implications of STK11 Mutation: Case Series
  Bahar Laderian, Prabhjot S. Mundi, Tito Fojo, Susan E. Bates
  The Oncologist. 2020-09-01
• 49 citations
  CDK4/6 Inhibition as a therapeutic strategy in breast cancer: palbociclib, ribociclib, and abemaciclib.
  Bahar Laderian, Tito Fojo
  Seminars in Oncology. 2017-12-01
• 34 citations
  Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults.
  Matthew F. Muldoon, Bahar Laderian, Dora C.-H. Kuan, Susan M. Sereika, Anna L. Marsland
  Journal of Internal Medicine. 2016-01-01

Abstracts/Posters

• A closer look at next generation sequencing (NGS) in breast cancer: A retrospective analysis
  Bahar Laderian, ANA CRISTINA Sandoval Leon, Loulwa Alsharhan, Dorraya El Ashry, Marc E. Lippman, ASCO 2017, Chicago, IL
• Complete Blood Count Parameters as Predictive Factors in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
  Diana Saravia Bahar Laderian Wungki Park Adrian Ishkanian Lisa Balfe Mohammad Jahanzeb, IASLC, Vienna, Austria
• Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single Institution
  Bahar Laderian, Diana Saravia, Ali Laderian, Adrian Ishkanian, Mohammad Jahanzeb5 1, IASLC, Vienna, Austria
• Medical Marijuana and Lung Cancer: Patients' Knowledge and Attitude towards Its Use
  Raja Mudad Bahar Laderian Madeline Krause, IASLC, Vienna, Austria
• Abstract P4-10-19: Utilization of next generation sequencing (NGS)-guided therapy in breast cancer (BC): Single-institution retrospective analysis of 315 patients
  Bahar Laderian, Robert Hsu, Ana Sandoval, Dorraya El-Ashry and Marc Lippman, 2019 San Antonio Breast Cancer Symposium, San Antonio, 12/13/2019
• Join now to see all

Lectures

• Role of radiomics to differentiate benign from malignant pheochromocytomas and paragangliomas on contrast enhanced CT scans. 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019